$ASBP News
Last published 2mo ago
- 2mo agoASBPAspire-Lakewood Holdings Board Approves $10 Million Share Repurchase ProgramACCESS NewswireBrings total authorized repurchase to $10 millionReflects leadership's view that Aspire-Lakewood's share price does not reflect the Company's financial strength or long-term growth opportunityIncreased
- 2mo agoASBPAspire Biopharma Holdings, INC. Announces Corporate Name Change To Aspire-Lakewood Holdings, Inc.ACCESS NewswireESTERO, FL / ACCESS Newswire / September 8, 2026 / Aspire Biopharma Holdings, Inc. , today announced that it has changed its corporate name from "Aspire
- 3mo agoASBPAspire Biopharma Holdings, Inc., to Present at Sidoti Virtual Investor Conference August 19thACCESS NewswireESTERO, FL / ACCESS Newswire / August 13, 2026 / Aspire Biopharma Holdings, Inc. , today announced that management will be present and host one-on-one meetings
- 3mo agoASBPAspire Biopharma Completes Acquisition of Dura Driver Control Systems, a Leading Global Automotive Supplier with a 100+ Year History and $200M+ in 2025 RevenueACCESS NewswireAcquisition represents a transformative milestone for Aspire, positioning the Company to rapidly evolve into a diversified, high-revenue enterpriseAdds an established global brand with scale in large and growing markets
- 3mo agoASBPFreestyle Motocross Legend Jarryd McNeil Named Newest Sponsored Athlete for Aspire Biopharma's BUZZ BOMB(TM)ACCESS NewswireHigh-Octane Partnership: Multi-time X Games medalist Jarryd McNeil joins BUZZ BOMB™ to fuel brand expansion in action sports.Consumer Connection: The collaboration strengthens BUZZ BOMB™'s commitment to delivering
- 4mo agoASBPAspire Biopharma's BUZZ BOMB(TM) Launches on Amazon, Introducing Next-Generation Caffeine Stick PacksACCESS NewswireThe brand expands nationwide distribution on Amazon, delivering a waterless, rapid-dissolve 50 mg caffeine powder built for active, on-the-go lifestyles. ESTERO, FL / ACCESS Newswire / June 24, 2026 / Aspire Biopharma
- 4mo agoASBPAspire Biopharma to Present at the Life Sciences Investor Forum on June 25thGlobeNewswireESTERO, Fla., June 17, 2026 (GLOBE NEWSWIRE) -- Aspire Biopharma Holdings, Inc.'s (NASDAQ:ASBP) ("Aspire" or the "Company"), today announced that it will present live at the Life Sciences Investor Forum hosted by
- 5mo agoASBPAspire Biopharma Announces Signing of Definitive Share Purchase Agreement to Acquire Dura Driver Control Systems, a Leading Global Automotive Supplier with a 100+ Year History and $200M+ in 2025 RevenueACCESS NewswireAdds an established global brand with scale in large and growing markets driven by trends in vehicle and mobility control systemsAcquisition significantly accelerates Aspire's revenue, earnings growth and cash flow
- 5mo agoASBPAspire Biopharma Issues Shareholder LetterACCESS NewswireESTERO, FL / ACCESS Newswire / May 28, 2026 / Aspire Biopharma Holdings, Inc. , a biopharmaceutical company developing multi-faceted patent-pending drug delivery technology, today
- 5mo agoASBPAspire Biopharma's BUZZ BOMBTM Partners with EoS Fitness to Empower High-Performance Lifestyles for Millions of MembersACCESS NewswireESTERO, FL / ACCESS Newswire / May 27, 2026 / Aspire Biopharma Holdings, Inc.'s wholly owned subsidiary Buzz Bomb Caffeine Company LC is proud to announce a strategic partnership
- 6mo agoASBPAspire Biopharma Holdings, Inc. Announces Approval Of Reverse Stock Split RatioACCESS NewswireESTERO, FL / ACCESS Newswire / May 7, 2026 / Aspire Biopharma Holdings, Inc. , a developer of a multi-faceted patent-pending drug delivery technology, today announced that it will
- 6mo agoASBPAspire Biopharma Announces $5.0 Million Share Repurchase ProgramACCESS NewswireESTERO, FL / ACCESS Newswire / April 27, 2026 / Aspire Biopharma Holdings, Inc. , a biopharmaceutical company developing multi-faceted patent-pending drug delivery technology,
- 6mo agoASBPAspire Biopharma Announces Closing of Second and Final Tranche of $21 Million Private Placement by Select Investors; Secures Commitment Letter for $22.5M Credit Facility to Fund the DCS AcquisitionACCESS NewswireCompany secures Commitment Letter from a leading financial institution of up to $22.5M to finance proposed acquisition of Dura Control Systems LOI to acquire DCS, a leading global automotive supplier with $200M+ in
- 6mo agoASBPAspire Biopharma's Buzz Bomb(TM) Caffeine Company's Brand Ambassador, Ashley Paulson, to Attempt Fastest 100-Mile Treadmill Run at 2026 Boston Marathon ExpoACCESS NewswireElite Ultra-Marathoner targets her second World Record in two months following historicUltra Jackpot 100 Win ESTERO, FL / ACCESS Newswire / April 17, 2026 / Aspire Biopharma Holdings, Inc.'s ("Aspire" or
- 6mo agoASBPAspire Biopharma Has Entered Into a Letter of Intent to Acquire a Leading Global Automotive Supplier With a 100+ Year History and $200M+ in 2025 RevenueACCESS NewswireESTERO, FL / ACCESS Newswire / April 16, 2026 / Aspire Biopharma Holdings, Inc. , a biopharmaceutical company developing multi-faceted patent-pending drug delivery technology,
- 7mo agoASBPAspire Biopharma's Buzz Bomb Caffeine Company Partners with Interwest Brokerage to Accelerate Retail ExpansionACCESS NewswireInterwest to Drive Regional Growth for BUZZ BOMB™ Across Major Grocery and Convenience ChannelsESTERO, FL / ACCESS Newswire / April 15, 2026 / Aspire Biopharma Holdings, Inc.'s ("Aspire" or the
- 7mo agoASBPAspire Biopharma's Subsidiary Announces Agreement with TruLife Distribution to Drive National Retail ExpansionACCESS NewswireAgreement Set to Expand BUZZ BOMB™ Distribution Across Natural, Specialty, and Mass Merchandiser ChannelsESTERO, FL / ACCESS Newswire / March 19, 2026 / Aspire Biopharma Holdings, Inc. ,
- 7mo agoASBPAspire Biopharma's Subsidiary, Buzz Bomb Caffeine Company, Appoints John Choe as Western Sales DirectorACCESS NewswireESTERO, FL / ACCESS Newswire / March 17, 2026 / Aspire Biopharma Holdings, Inc. , wholly owned subsidiary, Buzz Bomb Caffeine Company, has appointed 25-year industry veteran John Choe as Western
- 8mo agoASBPAspire Biopharma's Subsidiary to Feature BUZZ BOMB(TM) at The Health & Fitness Show 2026ACCESS NewswireESTERO, FL / ACCESS Newswire / March 12, 2026 / Aspire Biopharma Holdings, Inc. , wholly owned subsidiary, Buzz Bomb Caffeine Company, announces its participation at The Health & Fitness
- 8mo agoASBPAspire Biopharma's BUZZ BOMB(TM) Disrupts Energy Category with New Convenience Store PackACCESS NewswireConvenient Size at the Convenience StoreESTERO, FL / ACCESS Newswire / March 10, 2026 / Aspire Biopharma Holdings, Inc. , today announced that its subsidiary, Buzz Bomb Caffeine Company, is
- 8mo agoASBPAspire Biopharma Partners with Microsize to Develop Rapid-delivery Sublingual Powder Formulation of Alprazolam for Faster Anxiety ReliefACCESS NewswireCollaboration aims to create the first-ever sublingual alprazolam powder, addressing the need for faster-acting anxiety medication.Phase 1 clinical trial of the patent-pending, rapid-onset formulation planned for
- 8mo agoASBPAspire Biopharma's Buzz Bomb(TM) Caffeine Company Achieves Record Social Media Growth and Sales Surge Following World-Record Marathon SponsorshipACCESS NewswireBUZZ BOMB™ captures over 400,000 views and a spike in online revenue driven by strategic brand expansion and Ashley Paulson's historic record at the Jackpot Ultra Running Festival.ESTERO, FL / ACCESS Newswire /
- 8mo agoASBPAspire Biopharma Regains Full Compliance with Nasdaq Listing RequirementsACCESS NewswireCompany achieves minimum stockholders' equity rule; Nasdaq confirms matter is closedAspire maintains listing on the NasdaqESTERO, FL / ACCESS Newswire / February 20, 2026 / Aspire Biopharma Holdings, Inc.
- 8mo agoASBPAspire Biopharma's Buzz Bomb Caffeine Company Names ChicExecs as Public Relations Agency of RecordACCESS NewswireESTERO, FL / ACCESS Newswire / February 19, 2026 / Aspire Biopharma Holdings, Inc. today announced that its wholly owned subsidiary Buzz Bomb Caffeine Company - marketer of a
- 8mo agoASBPAspire Biopharma Files Provisional Patent Application for a Fast-Acting Sublingual Powder Formulation of Meclizine (Generic Dramamine(R))ACCESS NewswireNew delivery system targets rapid-onset relief for motion sickness and vertigo, modernizing the $450M global market for the active ingredient in Dramamine®.Meclizine was the top-prescribed antiemetic/antivertigo
- 9mo agoASBPAspire Biopharma Announces the Appointment of New Member to Its Board of DirectorsACCESS NewswireNew independent director Phillip Balatsos brings commercial and capital markets expertise to drive development patent-pending drug delivery platformESTERO, FL / ACCESS Newswire / February 13, 2026 / Aspire Biopharma
- 9mo agoASBPAspire Biopharma Files Provisional Patent Application for a Fast-Acting Sublingual Powder Formulation of Ondansetron (Generic Zofran(R))ACCESS NewswireNew sublingual delivery system designed to provide more rapid relief from nausea caused by cancer medicinesOndansetron, currently sold under the brand name Zofran®, was the 53rd most commonly prescribed medication
- 9mo agoASBPAspire Biopharma Announces $21 Million Private Placement by Select Investors, Strengthening Balance Sheet, Capital Position, and Fortifying Shareholder Equity to Meet Nasdaq RequirementsACCESS NewswireESTERO, FLORIDA / ACCESS Newswire / February 11, 2026 / Aspire Biopharma Holdings, Inc. , a biopharmaceutical company developing multi-faceted patent-pending drug delivery
- 9mo agoASBPAspire Biopharma Regains Compliance with Nasdaq Minimum Bid Price RequirementACCESS NewswireCompany achieves minimum $1.00 closing bid for 10 consecutive business days; Nasdaq confirms matter is closedESTERO, FLORIDA / ACCESS Newswire / February 10, 2026 / Aspire Biopharma Holdings, Inc. ("Aspire"
- 9mo agoASBPAspire Biopharma's Wholly Owned Subsidiary, Buzz Bomb Caffeine Company, to Showcase BUZZ BOMB(TM) Caffeine and its Innovative Sublingual Delivery Technology at The Sports & Active Nutrition SummitACCESS NewswireESTERO, FL / ACCESS Newswire / February 5, 2026 / Aspire Biopharma Holdings, Inc. , wholly owned subsidiary, Buzz Bomb Caffeine Company, a marketer of a proprietary sublingual
- 9mo agoASBPAspire Biopharma's Wholly Owned Subsidiary, Buzz Bomb Caffeine Company, Partners with Blue Shark Beverages to Expand Southern California DistributionACCESS NewswireESTERO, FL / ACCESS Newswire / February 3, 2026 / Aspire Biopharma Holdings, Inc. , wholly owned subsidiary, Buzz Bomb Caffeine Company, today announced a strategic brand
- 9mo agoASBPAspire Biopharma Secures Agreement with Microsize for Development of Novel Sublingual AspirinACCESS NewswireMicrosize brings over thirty years of expertise in specialized particle size engineering for the pharmaceutical industry, from pre-clinical development to full-scale GMP commercial manufacturing.ESTERO, FLORIDA / ACCESS
- 10mo agoASBPAspire Biopharma Welcomes Elite Ultra-Runner Ashley Paulson as Global Brand Ambassador for BUZZ BOMB(R) CaffeineACCESS NewswireA highly decorated endurance athlete, Ashley embodies the grit, energy, and rapid performance that BUZZ BOMB® was designed to supportBUZZ BOMB™ will power Ashley's elite training, recovery, and lifestyle
- 11mo agoASBPAspire Biopharma Granted Extension by Nasdaq Hearing Panel to Regain Compliance with Continued Listing RequirementsACCESS NewswireESTERO, FL / ACCESS Newswire / December 12, 2025 / Aspire Biopharma Holdings, Inc. , a developer of a multi-faceted patent-pending drug delivery technology, received notice (the
- 11mo agoASBPAspire Biopharma Provides Q3 2025 Business UpdateACCESS NewswireESTERO, FL / ACCESS Newswire / December 4, 2025 / Aspire Biopharma Holdings, Inc. , a developer of a multi-faceted patent-pending drug delivery technology,
- 11mo agoASBPAspire Biopharma Submits Pre-IND Meeting Request and Briefing Package to U.S. FDA for Sublingual Aspirin Product for Treatment of Suspected Acute Myocardial Infarction (Heart Attack)ACCESS NewswireESTERO, FLORIDA / ACCESS Newswire / December 2, 2025 / Aspire Biopharma Holdings, Inc. , a developer of a multi-faceted patent-pending drug delivery
- 11mo agoASBPAspire BioPharma Welcomes Dr. Mark J. Jaroszeski as New Scientific Team MemberACCESS NewswireESTERO, FL / ACCESS Newswire / November 26, 2025 / Aspire Biopharma Holdings, Inc. , a developer of a multi-faceted patent-pending drug delivery technology,
- 1y agoASBPAspire Biopharma Engages with Global Pharmaceutical Leaders at CPHI Frankfurt to Advance Partnership Discussions for its Sublingual High-Dose AspirinACCESS NewswireESTERO, FL / ACCESS Newswire / November 6, 2025 / Aspire Biopharma Holdings, Inc. , developer of a multi-faceted patent-pending drug delivery technology, today
- 1y agoASBPAspire Biopharma Holdings, Inc. Announces Filing of Omnibus Patent Application for Its Innovative Sublingual Drug Delivery PlatformACCESS NewswireESTERO, FLORIDA / ACCESS Newswire / October 6, 2025 / Aspire Biopharma Holdings, Inc. , developer of a multi-faceted patent-pending drug delivery technology,
- 1y agoASBPAspire Biopharma to Present at Noble Capital Markets 2025 Emerging Growth Virtual Equity Conference - October 8-9, 2025ACCESS NewswireShowcasing Disruptive Sublingual Drug Delivery Technology with Lead Program Targeting H2 2025 FDA Submission for Sublingual AspirinHighlighting Key 2026 Milestones for Needle-Free Semaglutide (Diabetes, Weight
- 1y agoASBPAspire Biopharma Announces Milestone Roadmap Targeting H2 2025 FDA Submission for Sublingual Aspirin and Key 2026 Milestones for Needle-Free Semaglutide (Diabetes, Weight Management) and more-rapid ED medicationACCESS NewswirePrioritizes High-Value Approved Drugs in Multi-Billion-Dollar Markets to Accelerate CommercializationFuture Platform Expansion into CNS, Men's Health, and Anti-Nausea ESTERO, FL / ACCESS Newswire / October 1, 2025 /
- 1y agoASBPAspire Biopharma Engages Well-Known Athletes and Influencers to Accelerate Consumer Awareness and Sales of its BUZZ BOMB(TM) Sublingual Caffeine Pre-Workout ProductACCESS NewswireBUZZ BOMB™ engages three specialized fitness influencers to grow the brandhttps://www.instagram.com/bobbymaximus/https://www.instagram.com/midwest_kong/https://www.instagram.com/ifbbpro_moose_the_stallion/The
- 1y agoASBPAspire Biopharma Announces Initial Production Order of Two Million Servings (100,000 20-packs) of BUZZ BOMB(TM) Pre-Workout SupplementACCESS NewswirePart of New Contract Manufacturing Agreement with SupraNaturals to Secure Additional Production CapacitySupraNaturals is a leading private label manufacturer in the health and wellness industryBUZZ BOMB™
- 1y agoASBPAspire Biopharma Announces Breakthrough Final Results from Clinical Trial of Investigational New Sublingual Aspirin Product for Treatment of Suspected Acute Myocardial Infarction (Heart Attack)ACCESS NewswireAspire's sublingual aspirin formulation significantly inhibited serum thromboxane B2 within the first two minutes after dosingTxB2 is a biomarker indicating aspirin's effect on platelet aggregation, the clumping
- 1y agoAIRSASBPBODIBZH+7Sidoti Events, LLC's Virtual August Micro-Cap ConferenceACCESS NewswireNEW YORK CITY, NY / ACCESS Newswire / August 19, 2025 / Sidoti Events, LLC, an affiliate of Sidoti & Company, LLC, has released the presentation schedule and weblinks for its two-day August Micro-Cap Conference
- 1y agoASBPAspire Biopharma Announces Positive Top-Line Results from Clinical Trial of Investigational New Sublingual Aspirin Product for Treatment of Suspected Acute Myocardial Infarction (Heart Attack)ACCESS NewswireAccording to the NIH, Acute myocardial infarction is a major cause of death, affecting nearly 3 million Americans each year and resulting in over a million deathsTrial demonstrates dramatically higher and more
- 1y agoASBPAspire Biopharma Holdings, Inc., to Present at Sidoti Virtual Investor Conference August 20ACCESS NewswireESTERO, FL / ACCESS Newswire / August 14, 2025 / Aspire Biopharma Holdings, Inc. , developer of a multi-faceted patent-pending drug and supplement delivery
- 1y agoASBPAspire Biopharma Successfully Launches BUZZ BOMB(TM) Pre-Workout Supplement at FitCon and FitExpo, Two of the Largest Fitness Conventions in the WorldACCESS NewswireBUZZ BOMB™ is bringing its unique delivery technology benefits to the multi-billion-dollar pre-workout to help athletes and fitness enthusiasts maximize their performance potential30,000 BUZZ BOMB™ sample
- 1y agoASBPAspire Biopharma Holdings, Inc. Unveils E-commerce Platform, Launches with its BUZZ BOMB Pre-Workout SupplementACCESS NewswireFirst sublingual pre-workout single-serving supplement that delivers 50mg of caffeine rapidly to the body, is now available to order via Aspire's new direct-to-consumer shopping experience ESTERO, FL / ACCESS Newswire /
- 1y agoASBPAspire Biopharma Holdings, Inc. Announces CEO TransitionACCESS NewswireKraig Higginson, Current Chairman of the Board, Appointed Interim CEO ESTERO, FL / ACCESS Newswire / July 30, 2025 / Aspire Biopharma Holdings, Inc. ,